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Abstract
The 13th International Conference on Bioinformatics (InCoB2014) was held for the first time in Australia, at Sydney, July
31-2 August, 2014. InCoB is the annual scientific gathering of the Asia-Pacific Bioinformatics Network (APBioNet), hosted
since 2002 in the Asia-Pacific region. Of 106 full papers submitted to the BMC track of InCoB2014, 50 (47.2%) were
accepted in BMC Bioinformatics, BMC Genomics and BMC Systems Biology supplements, with three papers in a new
BMC Medical Genomics supplement. While the majority of presenters and authors were from Asia and Australia, the
increasing number of US and European conference attendees augurs well for the international flavour of InCoB. Next
year’s InCoB will be held jointly with the Genome Informatics Workshop (GIW), September 9-11, 2015 in Tokyo, Japan,
with a view to integrate bioinformatics communities in the region.
Introduction
The 13th InCoB (International Conference on Bioinfor-
matics), an official conference of the Asia-Pacific Bioinfor-
matics Network (APBioNet) [1], was held in Sydney,
Australia. In keeping with InCoB’s tradition to locate the
conference in different Asia-Pacific countries, InCoB went
to Australia, for the first time, with the NSW Chief Scien-
tist and Engineer, Professor Mary O’Kane giving the open-
ing address. The conference was well attended by the local
community as well as participants from Asia-Pacific, Eur-
ope and USA, with scientists from Qatar and Turkey
attending InCoB for the first time. The plenary talks cov-
ered mutations in DNA, proteomics, RNA Biology, sys-
tems biology, mathematics, statistics and computer
science as well as bioinformatics training to equip scien-
tists with the current “tools of the trade” and best practice
methodologies, while the conference attendees presented
cutting edge research with three industry presentations, 89
orals as well as 45 posters.
Manuscript submission and review
We offered authors four tracks to submit manuscripts for
potential publication in the supplement issues of BMC
Bioinformatics, BMC Systems Biology or BMC Genomics
(BMC track) and PeerJ [2]. Of the 112 submitted manu-
scripts, 106 were in the BMC track. All manuscripts
received at least two reviews from the 92 member Pro-
gram Committee, supported by 35 additional reviewers
(Additional file 1). The first round of reviews resulted in
the provisional acceptance of 12 (11.3%) manuscripts, with
minor revisions. The authors of 45 manuscripts, including
three that were transferred by the Program Committee
Co-chairs to the PeerJ track, had to address major con-
cerns raised by the reviewers. After a second round of
review, another 38 (35.8%) manuscripts were provisionally
accepted pending minor revisions. In all cases, the
reviewers assessed the manuscripts at least twice and all
submissions were ranked based on the reviewers’ scores,
in accord with earlier InCoB publications [3].
The 20 articles in this supplement cover mainly
“genomic” topics, with three medically-oriented papers
going into BMC Medical Genomics [4] for the first time.
The InCoB2014 BMC Bioinformatics supplement [5]
comprises 16 manuscripts while another 11 papers are
presented in the BMC Systems Biology supplement [6].
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Five more submissions have been published in the
InCoB2014 PeerJ collection [7].
Sequencing, genomes and genome analysis
With genome sequencing technologies becoming more
and more accessible and affordable, the genetic origin of
the Marwari horse was established by whole genome
sequencing [8] while the chloroplast genome of Australia’s
macadamia nut tree [9]. funRNA [10] is a collection of
RNA interference (RNAi) genes, implicated in genome
defence as well as diverse cellular, developmental, and
physiological processes, from fungal, metazoan and plant
genomes along with bacterial and archaeal genomes.
Abbas et al. [11] have assessed de novo assembly software
for fungal genome data. Proteogenomics is increasingly
used for the accurate annotation of protein coding regions
using proteomic data. As currently available proteoge-
nomic tools are tailored specifically for human and eukar-
yotic data, Uszkoreit et al. [12] have developed a
proteogenomic analysis pipeline, specifically for bacterial
genomes.
Transcriptomics
Seven papers are devoted to transcriptome analysis
addressing a range of challenges from epigenetics [13,14]
to understanding transcript-level changes with diseases
[15-18]. dCAP [13] is a new method to simultaneously
detect constitutive and differential regulation of multiple
epigenetic factors from multiple sample datasets, while the
YNA database [14] provides an integrated data mining
platform for chromatin changes in yeast. Huang et al. [15]
have identified transcript-level changes implicated in bio-
logical dysfunction of energy metabolism and hemostasis
in schizophrenia while Yarmishyn et al. [16] have pin-
pointed a non-coding RNA as a novel marker of neuro-
blastoma progression. Sheng et al. [17] have identified the
most common microRNA (miRNA) editing events in
colon cancer. For non-small cell lung cancer, Mah et al.
[18] have identified a single single nucleotide polymorph-
ism (SNP) as a good prognostic marker of patient out-
come following chemotherapy. While transcripts are in
the main used as a measure of protein expression, Sun et
al. [19] have applied transcriptomics and pathway analysis
to improve protein identification from proteomics data,
especially where the sample size is limited to a few cells.
Functional genomics
Guanine-rich nucleotide sequences form four-stranded G-
quadruplex structures. Yano and Kato [20] have used hid-
den Markov Models to reliably identify these structures,
especially those involved in DNA transcription. Wu et al.
[21] have developed a novel algorithm (GM-SMCC), for
predicting the functional annotation of protein-coding
genes, applied successfully to the 2001 KDD cup yeast
gene datasets. Small ubiquitin-like modifier (or SUMO)
proteins covalently attached other proteins lead to sumoy-
lation, which is involved in various cellular processes,
including nuclear-cytosolic transport, transcriptional regu-
lation, apoptosis, protein stability, response to stress, and
cell cycle progression. Yavuz and Sezerman [22] have
developed an accurate support vector machine (SVM)-
based approach to identify these sites from sequence data,
as a precursor to experimental validation.
Pharmacogenomics
In the era of genomic medicine, it is possible that some
approved drug molecules can be used for diseases other
than those they were originally approved for. Yang and co-
workers [23] propose the concept of “Homopharma”, to
combine similar drug binding environments to better
understand molecular binding mechanisms for deploying
approved drugs for other diseases, known as “repurpos-
ing.” Tyagi et al. [24] have optimized arylthioindole com-
pounds for efficiently disrupting tubulin assembly towards
anti-cancer therapy, using QSAR and molecular dynamics
approaches.
Disease informatics
Taguchi and co-workers [25] have identified TINAGL1
and B3GALNT1 as novel key candidate genes in the treat-
ment of non-small cell lung cancer from gene expression
and epigenetic data, while sets of microRNA biomarkers
for detecting lung squamous cell carcinoma have been
proposed by Song et al. [26]. Xu et al. [27] have developed
a novel methodology, MHC2MIL for developing peptide-
based vaccines, benchmarked on 12 HLA DP and DQ
molecules.
Medical informatics
Papers specifically relating on genome-scale analysis with
a disease focus are presented in a new supplement in
BMC Medical Genomics and a brief overview of these
articles is presented here. With pandemic viral infections
spreading rapidly by jet travel, understanding cross-spe-
cies transmissibility of vectors is addressed by Tan and
co-workers [28] for influenza A, using a random forest
approach. In the quest for diagnostic biomarkers and
therapeutic targets, Nenadic and co-workers [29] have
developed a novel text-mining approach to successfully
identify novel genes and pathways for thyroid cancer sub-
types. While gene-based cancer biomarkers are typically
sets of hundreds or thousands of genes, Olsen et al. [30]
have analysed public proteogenomic data to zoom in on
just 32 tumor antigenic proteins as biomarkers for inva-
sive ductal carcinomas. These studies point to the com-
bined use of several “-omic” technologies as the focus of
future studies for understanding, detecting and
combatting diseases.
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Conclusion
With the growth in regional bioinformatics meetings,
including ISCB-Asia meetings and the 2013 IEEE Interna-
tional Conference on Bioinformatics and Biomedicine
(BIBM) in China [31], there is a growing community of
bioinformatics scientists in the Asia-Pacific. To consoli-
date multiple meetings and to provide cross-talk between
traditionally different bioinformatics communities, we
invite you to attend the 2015 InCoB meeting to be held
jointly with the Genome Informatics Workshop (GIW) in
Tokyo, Japan [32].
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